Testing effectiveness (Phase 2)Study completedNCT01323205
What this trial is testing
Investigation of the Safety, Tolerability and Potential Therapeutic Effects of JNJ-40411813 in Patients With Schizophrenia
Who this might be right for
Schizophrenia
Janssen Research & Development, LLC 100